Core Scientific Inc (CORZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | |
| Cash Flows From Operating Activities | |
| Net Income | -12,206 |
| Depreciation Amortization | 10,703 |
| Accounts receivable | -1,546 |
| Accounts payable and accrued liabilities | -1,770 |
| Other Working Capital | -21,127 |
| Other Operating Activity | 2,181 |
| Operating Cash Flow | $-23,765 |
| Cash Flows From Investing Activities | |
| PPE Investments | -1,568 |
| Net Acquisitions | -13,668 |
| Other Investing Activity | 92 |
| Investing Cash Flow | $-15,144 |
| Cash Flows From Financing Activities | |
| Debt Issued | 45,178 |
| Debt Repayment | -7,097 |
| Common Stock Issued | 2,642 |
| Financing Cash Flow | $40,723 |
| Beginning Cash Position | 6,907 |
| End Cash Position | 8,721 |
| Net Cash Flow | $1,814 |
| Free Cash Flow | |
| Operating Cash Flow | -23,765 |
| Capital Expenditure | -1,568 |
| Free Cash Flow | -25,333 |